Cargando…
Synthesis of chiral sulfinate esters by asymmetric condensation
Achiral sulfur functional groups, such as sulfonamide, sulfone, thiol and thioether, are common in drugs and natural products. By contrast, chiral sulfur functional groups are often neglected as pharmacophores(1–3), although sulfoximine, with its unique physicochemical and pharmacokinetic properties...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985065/ https://www.ncbi.nlm.nih.gov/pubmed/35158370 http://dx.doi.org/10.1038/s41586-022-04524-4 |
_version_ | 1784682293853421568 |
---|---|
author | Zhang, Xin Ang, Esther Cai Xia Yang, Ziqi Kee, Choon Wee Tan, Choon-Hong |
author_facet | Zhang, Xin Ang, Esther Cai Xia Yang, Ziqi Kee, Choon Wee Tan, Choon-Hong |
author_sort | Zhang, Xin |
collection | PubMed |
description | Achiral sulfur functional groups, such as sulfonamide, sulfone, thiol and thioether, are common in drugs and natural products. By contrast, chiral sulfur functional groups are often neglected as pharmacophores(1–3), although sulfoximine, with its unique physicochemical and pharmacokinetic properties(4,5), has been recently incorporated into several clinical candidates. Thus, other sulfur stereogenic centres, such as sulfinate ester, sulfinamide, sulfonimidate ester and sulfonimidamide, have started to attract attention. The diversity and complexity of these sulfur stereogenic centres have the potential to expand the chemical space for drug discovery(6–10). However, the installation of these structures enantioselectively into drug molecules is highly challenging. Here we report straightforward access to enantioenriched sulfinate esters via asymmetric condensation of prochiral sulfinates and alcohols using pentanidium as an organocatalyst. We successfully coupled a wide range of sulfinates and bioactive alcohols stereoselectively. The initial sulfinates can be prepared from existing sulfone and sulfonamide drugs, and the resulting sulfinate esters are versatile for transformations to diverse chiral sulfur pharmacophores. Through late-stage diversification(11,12) of celecoxib and other drug derivatives, we demonstrate the viability of this unified approach towards sulfur stereogenic centres. |
format | Online Article Text |
id | pubmed-8985065 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-89850652022-04-06 Synthesis of chiral sulfinate esters by asymmetric condensation Zhang, Xin Ang, Esther Cai Xia Yang, Ziqi Kee, Choon Wee Tan, Choon-Hong Nature Article Achiral sulfur functional groups, such as sulfonamide, sulfone, thiol and thioether, are common in drugs and natural products. By contrast, chiral sulfur functional groups are often neglected as pharmacophores(1–3), although sulfoximine, with its unique physicochemical and pharmacokinetic properties(4,5), has been recently incorporated into several clinical candidates. Thus, other sulfur stereogenic centres, such as sulfinate ester, sulfinamide, sulfonimidate ester and sulfonimidamide, have started to attract attention. The diversity and complexity of these sulfur stereogenic centres have the potential to expand the chemical space for drug discovery(6–10). However, the installation of these structures enantioselectively into drug molecules is highly challenging. Here we report straightforward access to enantioenriched sulfinate esters via asymmetric condensation of prochiral sulfinates and alcohols using pentanidium as an organocatalyst. We successfully coupled a wide range of sulfinates and bioactive alcohols stereoselectively. The initial sulfinates can be prepared from existing sulfone and sulfonamide drugs, and the resulting sulfinate esters are versatile for transformations to diverse chiral sulfur pharmacophores. Through late-stage diversification(11,12) of celecoxib and other drug derivatives, we demonstrate the viability of this unified approach towards sulfur stereogenic centres. Nature Publishing Group UK 2022-02-14 2022 /pmc/articles/PMC8985065/ /pubmed/35158370 http://dx.doi.org/10.1038/s41586-022-04524-4 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Zhang, Xin Ang, Esther Cai Xia Yang, Ziqi Kee, Choon Wee Tan, Choon-Hong Synthesis of chiral sulfinate esters by asymmetric condensation |
title | Synthesis of chiral sulfinate esters by asymmetric condensation |
title_full | Synthesis of chiral sulfinate esters by asymmetric condensation |
title_fullStr | Synthesis of chiral sulfinate esters by asymmetric condensation |
title_full_unstemmed | Synthesis of chiral sulfinate esters by asymmetric condensation |
title_short | Synthesis of chiral sulfinate esters by asymmetric condensation |
title_sort | synthesis of chiral sulfinate esters by asymmetric condensation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985065/ https://www.ncbi.nlm.nih.gov/pubmed/35158370 http://dx.doi.org/10.1038/s41586-022-04524-4 |
work_keys_str_mv | AT zhangxin synthesisofchiralsulfinateestersbyasymmetriccondensation AT angesthercaixia synthesisofchiralsulfinateestersbyasymmetriccondensation AT yangziqi synthesisofchiralsulfinateestersbyasymmetriccondensation AT keechoonwee synthesisofchiralsulfinateestersbyasymmetriccondensation AT tanchoonhong synthesisofchiralsulfinateestersbyasymmetriccondensation |